⌕
Guardant Health · GH · Nasdaq
Tenet 48 · Mixed
Compare
$143.28−0.52%At closeTenet 48 · Mixed
$143.28−0.75 (−0.52%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Guardant Health (GH) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is GH's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Business WireNov 13, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on October 13, 2026, the Compensation Committee of Guardant's Board of Directors approved…

GH −0.5% todayRead at source ↗
● Business WireNov 12, 2026 · 01:09 ET
Guardant Health Prices $500 Million Convertible Senior Notes Offering

PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced the pricing of its offering of $500 million aggregate principal am…

GH −0.5% todayRead at source ↗
● Business WireNov 11, 2026 · 16:17 ET
Guardant Health Announces Proposed $500.0 Million Offering of Convertible Senior Notes Due 2032

PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (“Guardant Health”) (Nasdaq: GH), a leading precision oncology company, today announced its intention to offer $500.0 million aggregate principal amount o…

GH −0.5% todayRead at source ↗
● Business WireNov 11, 2026 · 08:46 ETCOMPANY'S OWN WORDS
Guardant Health Introduces New Epigenomic Applications Providing Deeper Insights for Treatment Selection with Guardant360® Liquid

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced new applications for Guardant360® Liquid designed to help oncologists understand how a patient…

GH −0.5% todayRead at source ↗
● Business WireNov 10, 2026 · 16:05 ETEARNINGS EXPECTED BY FEB 22
PRECISION Study Published in ESMO Open Highlights Utility of Guardant360® Liquid and Guardant Reveal® to Assess Recurrence Risk After Surgery for Colorectal Cancer Metastases

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that ESMO Open has published results from PRECISION, a prospective multicenter observational s…

GH −0.5% todayRead at source ↗
● Business WireNov 9, 2026 · 16:30 ET
Guardant Health to Participate in Upcoming Investor Conferences

PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Jefferies Glo…

GH −0.5% todayRead at source ↗
● MarketBeatNov 5, 2026 · 21:15 ETEARNINGS EXPECTED BY FEB 22
What Guardant Health (GH) Said on Its Q3 Earnings Call

Guardant Health NASDAQ: GH raised its full-year 2026 revenue forecast after third-quarter sales increased 36%, driven by growth in its oncology testing business and demand for its Shield blood-based cancer screening test…

GH −0.5% todayRead at source ↗
● Zacks Investment ResearchNov 5, 2026 · 21:02 ETEARNINGS EXPECTED BY FEB 22
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates

Guardant Health (GH) came out with a quarterly loss of $0.29 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.39 per share a year ago.…

GH −0.5% todayRead at source ↗
● Zacks Investment ResearchNov 5, 2026 · 20:31 ETEARNINGS EXPECTED BY FEB 22
Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Guardant Health (GH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the …

GH −0.5% todayRead at source ↗
● Business WireNov 5, 2026 · 16:05 ETEARNINGS EXPECTED BY FEB 22
Guardant Health Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2026. Third Quarter 2026 Financia…

GH −0.5% todayRead at source ↗
● Zacks Investment ResearchNov 4, 2026 · 10:16 ETEARNINGS EXPECTED BY FEB 22
Countdown to Guardant Health (GH) Q3 Earnings: Wall Street Forecasts for Key Metrics

Evaluate the expected performance of Guardant Health (GH) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better i…

GH −0.5% todayRead at source ↗
● Business WireNov 3, 2026 · 16:30 ET
Kevin Sayer Joins Guardant Health Board of Directors

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the appointment of Kevin Sayer to its board of directors. Mr. Sayer is former CEO of Dexcom, I…

GH −0.5% todayRead at source ↗
● Business WireNov 3, 2026 · 08:05 ETCOMPANY'S OWN WORDS
Guardant Health Wins 2026 Prix Galien USA Award for Best Medical Technology for Shield Blood Test

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced it received the 2026 Prix Galien USA Award for Best Medical Technology for Shield™, the leading bloo…

GH −0.5% todayRead at source ↗
● Zacks Investment ResearchOct 29, 2026 · 11:01 ETEARNINGS EXPECTED BY FEB 22
Guardant Health (GH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Guardant Health (GH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

GH −0.5% todayRead at source ↗
● Business WireOct 29, 2026 · 08:05 ETCOMPANY'S OWN WORDS
Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for Pennsylvanians

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, applauded the enactment of a new law (HB 1123) in Pennsylvania aligning insurance coverage for colorectal canc…

GH −0.5% todayRead at source ↗
● BenzingaOct 23, 2026 · 08:37 ET
This Guardant Health Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.…

GH −0.5% todayRead at source ↗
● 247 WallstOct 23, 2026 · 07:51 ET
Here Are Friday’s Top Wall Street Analyst Research Calls: Deckers Outdoor, Globe Life, Guardant Health, Hess Midstream LP, Kimberly-Clark, Natera, NVR, SpaceX, Thermo Fisher Scientific, and More

A wild Thursday saw Treasury yields crater, oil surge past $111, crypto liquidations top $431 million, and Meta's cash flow surprise rattle markets. Now analysts are reshuffling their calls on some of the week's most clo…

GH −0.5% todayRead at source ↗
● Defense WorldOct 22, 2026 · 02:45 ET
Guardant Health, Inc. (NASDAQ:GH) Stock Has Average Price Target of $190.00

Guardant Health, Inc. (NASDAQ: GH - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-five ratings firms that are currently covering the stock, Marketbeat Ratings reports. One…

GH −0.5% todayRead at source ↗
● Business WireOct 20, 2026 · 09:02 ET
Guardant Health Highlights Broad Liquid Biopsy Research Portfolio at ESMO Congress 2026

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the company and its research collaborators will present 25 abstracts—including five rapid…

GH −0.5% todayRead at source ↗
● GuruFocusOct 15, 2026 · 09:00 ET
Guardant Health Shield Blood Test Demonstrates Leading Screening Adherence and CRC Deaths Averted Compared to Stool-Based Tests

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators presented new data showing…

GH −0.5% todayRead at source ↗
● Defense WorldOct 15, 2026 · 02:29 ET
Reviewing The Pennant Group (NASDAQ:PNTG) and Guardant Health (NASDAQ:GH)

Guardant Health (NASDAQ: GH - Get Free Report) and The Pennant Group (NASDAQ: PNTG - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the stren…

GH −0.5% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 22. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

NVDA29−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just GH · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.